Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04334135 · ClinicalTrials.gov registry record · NA
The Influence of Mitochondrial-Derived Reactive Oxygen Species on Racial Disparities in Neurovascular Function
A NA study of Blood Pressure and Cardiovascular Risk Factor, sponsored by Auburn University.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT04334135: Recruiting NA study of Blood Pressure and Cardiovascular Risk Factor, sponsored by Auburn University.
NCT04334135 is a NA study of Blood Pressure and Cardiovascular Risk Factor that is actively recruiting participants, run by Auburn University. The registered enrollment target is 60 participants, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04334135, a NA study of Blood Pressure and Cardiovascular Risk Factor, is actively recruiting participants, sponsored by Auburn University.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Black individuals are at increased cardiovascular disease risk. The central goal of the study is to determine if mitochondrial reactive oxygen species influence blood vessel function and nervous system regulation of blood pressure differentially in black, compared to white individuals. These findings may help to explain a potential mechanism that contributes to racial disparities in blood pressure and cardiovascular disease risk. A secondary goal is to determine if mitochondrial reactive oxygen species improves blood pressure and vascular function in individuals with elevated blood pressure and stage 1 hypertension.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT MitoQ
Study Locations (1)
Alabama
- Kinesiology Building - Auburn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-10-02 |
| Est. Completion | 2025-08-31 |
| Phase | NA |
What NCT04334135 shows while recruiting
NCT04334135 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (79% lower).
The record links to 4 conditions, with Blood Pressure appearing as the primary indexed condition, and to 1 intervention - of which MitoQ is the first listed.
NCT04334135 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT04334135 about?
NCT04334135 is a clinical study titled "The Influence of Mitochondrial-Derived Reactive Oxygen Species on Racial Disparities in Neurovascular Function". Black individuals are at increased cardiovascular disease risk. The central goal of the study is to determine if mitochondrial reactive oxygen species influence blood vessel function and nervous system regulation of blood pressure differentially in black, compared to white individuals. These finding...
What is the current status of trial NCT04334135?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2020-10-02. Estimated completion is 2025-08-31.
What conditions does trial NCT04334135 study?
This clinical trial studies the following conditions: Blood Pressure, Cardiovascular Risk Factor, Racial Disparities, Renal Function.
What interventions are being tested in trial NCT04334135?
The interventions under investigation include: MitoQ (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04334135?
This trial is sponsored by Auburn University, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04334135 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04334135's enrollment target sits among peer trials
60 52nd of 101 higher than 48 of 101 other Blood Pressure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
The GUARDIAN Trial
RECRUITING · NA
-
The Venous Distension Reflex and Orthostatic Hypertension
RECRUITING · NA
-
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
RECRUITING · NA
-
The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI